BIATRA

This brand name is authorized in Nigeria.

Active ingredients

The drug BIATRA contains one active pharmaceutical ingredient (API):

1	Itraconazole UNII 304NUG5GF4 - ITRACONAZOLE
	Itraconazole is a triazole derivative that inhibits fungal 14α-demethylase, resulting in a depletion of ergosterol and disruption of membrane synthesis by fungi.
	Read more about Itraconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5596	Capsule	Biatra Capsule CAP 100 mg 1 x 10's (in blister)	Hard gelatin capsule	27/06/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC02	Itraconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5596